63.52
전일 마감가:
$63.02
열려 있는:
$62.45
하루 거래량:
190.49K
Relative Volume:
0.22
시가총액:
$3.17B
수익:
$1.36B
순이익/손실:
$123.81M
주가수익비율:
26.36
EPS:
2.41
순현금흐름:
$20.35M
1주 성능:
-1.21%
1개월 성능:
-3.10%
6개월 성능:
-19.97%
1년 성능:
-24.59%
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HAE
Haemonetics Corp
|
63.45 | 3.17B | 1.36B | 123.81M | 20.35M | 2.41 |
![]()
ABT
Abbott Laboratories
|
131.28 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
99.97 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
376.19 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.42 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.77 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2024-12-06 | 개시 | JP Morgan | Overweight |
2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-09-13 | 개시 | CL King | Buy |
2024-09-11 | 개시 | BofA Securities | Neutral |
2024-09-10 | 개시 | BTIG Research | Buy |
2024-06-12 | 업그레이드 | Needham | Hold → Buy |
2022-10-13 | 개시 | Mizuho | Buy |
2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
2021-08-17 | 재개 | Raymond James | Outperform |
2021-06-17 | 개시 | Citigroup | Buy |
2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
2020-01-10 | 개시 | Needham | Buy |
2019-08-07 | 재확인 | Barrington Research | Outperform |
2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2019-05-08 | 재확인 | Barrington Research | Outperform |
2018-08-09 | 재확인 | Barrington Research | Outperform |
2018-02-07 | 재확인 | Barrington Research | Outperform |
2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2017-11-08 | 재확인 | Barrington Research | Outperform |
2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2016-11-07 | 재확인 | The Benchmark Company | Hold |
2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
2016-08-02 | 재확인 | Jefferies | Buy |
2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? - Yahoo Finance
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - Yahoo Finance
10 Pro-Life Companies to Invest In Now - Insider Monkey
A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity - Yahoo Finance
Fractional Flow Reserve Market Set for 11.27% CAGR Growth by 2031 - openPR
Haemonetics (NYSE:HAE) Given New $104.00 Price Target at Needham & Company LLC - Defense World
Is it Apt to Retain HAE Stock in Your Portfolio for Now? - Nasdaq
Demystifying Haemonetics: Insights From 5 Analyst Reviews - Nasdaq
Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating -March 18, 2025 at 06:53 am EDT - MarketScreener
Haemonetics FY2025 EPS Estimate Reduced by Zacks Research - Defense World
Haemonetics Corp (HAE) Shares Down 3.63% on Mar 12 - GuruFocus.com
How Do Investors Really Feel About Haemonetics? - Benzinga
Haemonetics at Raymond James Conference: Strategic Growth Insights - Investing.com
Haemonetics at Raymond James Conference: Strategic Growth Insights By Investing.com - Investing.com UK
Haemonetics Names Chief Operating Officer, Chief Commercial Officer -March 03, 2025 at 05:40 pm EST - Marketscreener.com
Haemonetics appoints new executive leadershi - Investing.com
Haemonetics Announces Executive Leadership Updates - Quantisnow
Global Blood Bank Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Haemonetics Corp. to Host Earnings Call - ACCESS Newswire
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Quantisnow
Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World
Van ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics FY2025 EPS Forecast Decreased by Zacks Research - Defense World
(HAE)Analyzing Haemonetics's Short Interest - Benzinga
SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Brokerages - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World
Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat
Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives $101.67 Consensus Target Price from Analysts - Defense World
Haemonetics (NYSE:HAE) Price Target Cut to $100.00 by Analysts at JMP Securities - MarketBeat
Haemonetics (NYSE:HAE) Raised to "Buy" at StockNews.com - MarketBeat
Haemonetics (NYSE:HAE) Downgraded to Underperform Rating by Bank of America - MarketBeat
Haemonetics' (HAE) "Strong-Buy" Rating Reaffirmed at Raymond James - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 52-Week Low After Analyst Downgrade - Defense World
Barrington Research Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Haemonetics (NYSE:HAE) Upgraded at StockNews.com - Defense World
Haemonetics (NYSE:HAE) Shares Gap Down Following Weak Earnings - MarketBeat
It is Poised to be a Bull Market for Haemonetics Corp (HAE) - SETE News
Haemonetics (HAE) Projected to Post Earnings on Thursday - MarketBeat
Haemonetics (NYSE:HAE) Releases FY 2025 Earnings Guidance - MarketBeat
Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat
Haemonetics (HAE) Q3 Earnings Meet Estimates - MSN
Haemonetics Corp [HAE] Former Officer makes an insider purchase of 6,238 shares worth 0.57 million. - Knox Daily
Haemonetics' stock slides on revenue miss - MSN
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):